Arya Vaidya Sala has commissioned a new drug manufacturing unit at Nanjangud in Karnataka. Switching on ceremony of the Unit was performed by Dr. P.K. Warrier, Managing Trustee & Chief Physician on 21.10.09. Trial runs commenced the same day. The new Unit has now received GMP registration and manufacturing license from the Drug Controlling Authority of the State of Karnataka.

 

 

The Nanjangud Unit is designed and established by incorporating modern technological and pharmaceutical concepts and methods in all possible aspects. The Unit was set up with the aim of expanding the manufacturing capacity of AVS and to upgrade the production methods for meeting the increasing needs of Ayurvedic sector.

 

A range of new medicines has been formulated for the Unit by the Product Development Department established for the purpose. Based on classical Ayurvedic knowledge and our own acquired experience, these “new generation medicaments” are also endowed with better user-compliance. It is envisaged that these formulations will be supported by modern scientific data and will be channelled through prescriptions of modern practitioners and Ayurvedic physicians, thereby enabling us to expand the scope and reach of Ayurvedic medicines. The Nanjangud Unit is expected to represent the modern face of authentic Ayurveda with its upgraded manufacturing capability and a new crop of medicaments. In addition to the new generation medicaments, this Unit will also take up production of classical and other formulations required by the existing Dealership network and its dedicated fraternity of physicians as and when required.